Cargando…
The EGR2 targets LAG-3 and 4-1BB describe and regulate dysfunctional antigen-specific CD8(+) T cells in the tumor microenvironment
Although the presence of tumor-infiltrating lymphocytes (TILs) indicates an endogenous antitumor response, immune regulatory pathways can subvert the effector phase and enable tumor escape. Negative regulatory pathways include extrinsic suppression mechanisms, but also a T cell–intrinsic dysfunction...
Autores principales: | Williams, Jason B., Horton, Brendan L., Zheng, Yan, Duan, Yukan, Powell, Jonathan D., Gajewski, Thomas F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5294847/ https://www.ncbi.nlm.nih.gov/pubmed/28115575 http://dx.doi.org/10.1084/jem.20160485 |
Ejemplares similares
-
LAG-3 and 4-1BB identify dysfunctional antigen-specific T cells in the tumor microenvironment and combinatorial LAG-3/4-1BB targeting gives synergistic tumor control
por: Williams, Jason B, et al.
Publicado: (2015) -
Agonistic 4-1bb antibodies in combination with inhibitory antibodies against CTLA-4, PD-L1 or LAG-3 ACT on CD8+ T cells in the tumor microenvironment and synergize to promote regression of established tumors
por: Horton, Brendan, et al.
Publicado: (2014) -
Agonist anti-4-1BB plus neutralizing anti-CTLA-4 or -PD-L1 synergize to promote tumor regression by rescuing dying dysfunctional CD8+ T cells within the tumor microenvironment
por: Horton, Brendan, et al.
Publicado: (2015) -
Egr2 targets identify a population of dysfunctional T cells in the tumor microenvironment with immune modulatory properties
por: Williams, Jason, et al.
Publicado: (2013) -
Egr2 targets identify a population of dysfunctional T cells in the tumor microenvironment with immune modulatory properties
por: Williams, Jason, et al.
Publicado: (2014)